Notice of Proposed Sale · 144
CG Oncology, Inc.
CGONNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- CG Oncology, Inc.
- Issuer CIK
- 0001991792
- SEC file number
- 001-41925
- Phone
- 9494093700
- Person for whose account securities are to be sold
- JAMES MULAY
- Relationships to issuer
- Director
- Street
- 3000 Pegasus Park Drive, Suite 1640
- City
- Dallas
- State / country code
- TX
- Postal code
- 75247
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 20,237 | 1,483,776.84 | 88,202,473 | 07/10/2026 | NASDAQ | Morgan Stanley Smith Barney LLC Executive Financial Services |
Broker / market maker — proposed row 1, entry 1
- Name
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Street
- 1 New York Plaza
- Street (continued)
- 8th Floor
- City
- New York
- State / country code
- NY
- Postal code
- 10004
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 07/10/2026 | Exercise of Stock Options | Issuer | 20,237 | N | 07/10/2026 | Cash |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| 10b5-1 Sales for JAMES MULAY | Common | 06/15/2026 | 1,964 | 118,075.68 |
| 10b5-1 Sales for JAMES MULAY | Common | 04/17/2026 | 15,600 | 1,139,024.64 |
Seller — prior-sale row 1, entry 1
- Name
- 10b5-1 Sales for JAMES MULAY
- Street
- 3000 Pegasus Park Drive, Suite 1640
- City
- Dallas
- State / country code
- TX
- Postal code
- 75247
Seller — prior-sale row 2, entry 1
- Name
- 10b5-1 Sales for JAMES MULAY
- Street
- 3000 Pegasus Park Drive, Suite 1640
- City
- Dallas
- State / country code
- TX
- Postal code
- 75247
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Notice signature
- Notice date
- 07/10/2026
- Signed
- /s/ James Mulay
- Plan adoption dates
- 03/27/2026
Company context
CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. CG Oncology sees a world where urologic cancer patients may benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life. To learn more, please visit: www.cgoncology.com.